{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:35:23Z","timestamp":1790681723491,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018232","name":"University of Pennsylvania The Orphan Disease Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.omtm.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:11:30Z","timestamp":1650373890000},"page":"392-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-0295","authenticated-orcid":false,"given":"Edina","family":"Poletto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4268-2391","authenticated-orcid":false,"given":"Pasqualina","family":"Colella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa N.","family":"Pimentel Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaukat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1598-5861","authenticated-orcid":false,"given":"Guilherme","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-1154","authenticated-orcid":false,"given":"Natalia","family":"Gomez-Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2022.04.009_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MOH.0000000000000385","article-title":"The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation","volume":"24","author":"Dever","year":"2017","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.omtm.2022.04.009_bib2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.04.009_bib3","doi-asserted-by":"crossref","first-page":"e00471","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.omtm.2022.04.009_bib4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tig.2018.05.004","article-title":"Gene editing on center stage","volume":"34","author":"Bak","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.omtm.2022.04.009_bib5","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1172\/JCI140189","article-title":"BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicity","volume":"130","author":"Demirci","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2022.04.009_bib6","doi-asserted-by":"crossref","first-page":"aaw3768","DOI":"10.1126\/scitranslmed.aaw3768","article-title":"Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates","volume":"11","author":"Humbert","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.04.009_bib9","doi-asserted-by":"crossref","first-page":"360ra134","DOI":"10.1126\/scitranslmed.aaf9336","article-title":"Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells","volume":"8","author":"DeWitt","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib10","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/mt.2016.148","article-title":"CRISPR\/Cas9-Mediated correction of the sickle mutation in human CD34+ cells","volume":"24","author":"Hoban","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.009_bib11","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1093\/nar\/gkz475","article-title":"Highly efficient editing of the beta-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease","volume":"47","author":"Park","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2022.04.009_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41591-021-01284-y","article-title":"Gene replacement of alpha-globin with beta-globin restores hemoglobin balance in beta-thalassemia-derived hematopoietic stem and progenitor cells","volume":"27","author":"Cromer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.04.009_bib14","doi-asserted-by":"crossref","first-page":"eaan0820","DOI":"10.1126\/scitranslmed.aan0820","article-title":"Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1","volume":"9","author":"Schiroli","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib15","doi-asserted-by":"crossref","first-page":"eaah3480","DOI":"10.1126\/scitranslmed.aah3480","article-title":"CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease","volume":"9","author":"De Ravin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nbt.3513","article-title":"Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease","volume":"34","author":"De Ravin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2022.04.009_bib17","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.15252\/emmm.201707540","article-title":"Therapeutic gene editing in CD34(+) hematopoietic progenitors from Fanconi anemia patients","volume":"9","author":"Diez","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/hum.2017.047","article-title":"Comparison of zinc finger nucleases versus CRISPR-specific nucleases for genome editing of the Wiskott-Aldrich syndrome locus","volume":"29","author":"Gutierrez-Guerrero","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.009_bib19","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.04.009_bib20","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1038\/s41467-019-11962-8","article-title":"Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I","volume":"10","author":"Gomez-Ospina","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.04.009_bib21","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1038\/s41467-020-17148-x","article-title":"Engineering monocyte\/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing","volume":"11","author":"Scharenberg","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.04.009_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2022.04.009_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13420","article-title":"Targeted genome editing in human repopulating haematopoietic stem cells","volume":"510","author":"Genovese","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.04.009_bib24","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.celrep.2018.04.103","article-title":"Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome","volume":"23","author":"Kuo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2022.04.009_bib25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates","volume":"27","author":"Romero","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.009_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.omtm.2019.10.010","article-title":"Immunoresponse to gene-modified hematopoietic stem cells","volume":"16","author":"Drysdale","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.04.009_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fped.2019.00434","article-title":"Conditioning perspectives for primary immunodeficiency stem cell transplants","volume":"7","author":"Shaw","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.omtm.2022.04.009_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ymthe.2020.11.020","article-title":"Update on clinical ex\u00a0vivo hematopoietic stem cell gene therapy for inherited monogenic diseases","volume":"29","author":"Tucci","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.009_bib29","first-page":"1384","article-title":"Human cell engraftment after busulfan or irradiation conditioning of NOD\/SCID mice","volume":"91","author":"Robert-Richard","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2022.04.009_bib30","first-page":"5414","article-title":"Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells","volume":"63","author":"Meng","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2022.04.009_bib31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.bbmt.2016.06.006","article-title":"Busulfan triggers intrinsic mitochondrial-dependent platelet apoptosis independent of platelet activation","volume":"22","author":"Qiao","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2022.04.009_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1634\/stemcells.2008-0583","article-title":"Busulfan produces efficient human cell engraftment in NOD\/LtSz-Scid IL2R\u03b3 null mice","volume":"27","author":"Hayakawa","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2022.04.009_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10875-010-9478-2","article-title":"Human B cell development and antibody production in humanized NOD\/SCID\/IL-2R\u03b3null (NSG) mice conditioned by busulfan","volume":"31","author":"Choi","year":"2011","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.omtm.2022.04.009_bib34","doi-asserted-by":"crossref","first-page":"e74361","DOI":"10.1371\/journal.pone.0074361","article-title":"Busulfan administration flexibility increases the applicability of scid repopulating cell assay in NSG mouse model","volume":"8","author":"Chevaleyre","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2022.04.009_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2022.04.009_bib36","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1073\/pnas.1205858109","article-title":"Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation","volume":"109","author":"Capotondo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtm.2022.04.009_bib37","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/mt.2013.29","article-title":"Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation","volume":"21","author":"Wilkinson","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.009_bib38","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.04.009_bib39","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.04.009_bib40","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1371\/journal.pbio.0030339","article-title":"The geographic spread of the CCR5 \u039432 HIV-resistance allele","volume":"3","author":"Novembre","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtm.2022.04.009_bib41","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.04.009_bib42","doi-asserted-by":"crossref","first-page":"e1701211","DOI":"10.1126\/sciadv.1701211","article-title":"Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells","volume":"3","author":"Capotondo","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2022.04.009_bib43","doi-asserted-by":"crossref","first-page":"e58544","DOI":"10.1371\/journal.pone.0058544","article-title":"Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias","volume":"8","author":"Kierdorf","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2022.04.009_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12974-019-1410-y","article-title":"Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours","volume":"16","author":"Youshani","year":"2019","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.omtm.2022.04.009_bib45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinchem\/38.6.803","article-title":"Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue","volume":"38","author":"de Jong","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtm.2022.04.009_bib46","first-page":"006","article-title":"Assay for glycosaminoglycans by tandem mass spectrometry and its applications","volume":"2014","author":"Tomatsu","year":"2014","journal-title":"J.\u00a0Anal. Bioanal. Tech."},{"key":"10.1016\/j.omtm.2022.04.009_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.stemcr.2019.05.016","article-title":"Autologous, gene-modified hematopoietic stem and progenitor cells repopulate the central nervous system with distinct clonal variants","volume":"13","author":"Peterson","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2022.04.009_bib48","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/mt.2013.141","article-title":"Myeloid\/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease","volume":"21","author":"Sergijenko","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.009_bib49","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/scd.2015.0289","article-title":"Myeloid engraftment in humanized mice: impact of granulocyte-colony stimulating factor treatment and transgenic mouse strain","volume":"25","author":"Coughlan","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.omtm.2022.04.009_bib50","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2010-08-301507","article-title":"Development of human CD4+FoxP3+ regulatory T\u00a0cells in human stem cell factor\u2013, granulocyte-macrophage colony-stimulating factor\u2013, and interleukin-3\u2013expressing NOD-SCID IL2R\u03b3null humanized mice","volume":"117","author":"Billerbeck","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2022.04.009_bib51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0403-367","article-title":"Safety of retroviral gene marking with a truncated NGF receptor","volume":"9","author":"Bonini","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib52","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.04.009_bib53","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/stem.2935","article-title":"Improving gene editing outcomes in human hematopoietic stem and progenitor cells by temporal control of DNA repair","volume":"37","author":"Lomova","year":"2019","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2022.04.009_bib54","doi-asserted-by":"crossref","first-page":"108093","DOI":"10.1016\/j.celrep.2020.108093","article-title":"Controlled cycling and quiescence enables efficient HDR in engraftment-enriched adult hematopoietic stem and progenitor cells","volume":"32","author":"Shin","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2022.04.009_bib55","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/S2352-3026(19)30021-3","article-title":"Lentiviral haemopoietic stem\/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1\/2 clinical study","volume":"6","author":"Ferrua","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.omtm.2022.04.009_bib56","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2022.04.009_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","article-title":"Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent \u00df-thalassemia","volume":"25","author":"Marktel","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.omtm.2020.11.018","article-title":"Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector","volume":"20","author":"Dahl","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.04.009_bib59","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2022.04.009_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2022.04.009_bib61","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V83.8.2360.2360","article-title":"Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice","volume":"83","author":"Xun","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2022.04.009_bib62","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/mt.2011.312","article-title":"Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys","volume":"20","author":"Tarantal","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.009_bib63","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.ymthe.2019.05.022","article-title":"Busulfan combined with immunosuppression allows efficient engraftment of gene-modified cells in a rhesus macaque model","volume":"27","author":"Uchida","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.009_bib64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fneur.2017.00075","article-title":"Bone marrow-derived cell accumulation in the spinal cord is independent of peripheral mobilization in a mouse model of amyotrophic lateral sclerosis","volume":"8","author":"Peake","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtm.2022.04.009_bib65","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41591-022-01691-9","article-title":"Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain","volume":"28","author":"Sailor","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2022.04.009_bib66","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2022.04.009_bib67","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","article-title":"Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood","volume":"1","author":"Majeti","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2022.04.009_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-59745-182-6_11","article-title":"Hematopoietic stem cell transplant in mice by intra-femoral injection","volume":"430","author":"Zhan","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2022.04.009_bib69","doi-asserted-by":"crossref","DOI":"10.3791\/60335","article-title":"Simultaneous flow cytometric characterization of multiple cell types retrieved from mouse brain\/spinal cord through different homogenization methods","author":"Molina Estevez","year":"2019","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtm.2022.04.009_bib70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbr.2012.04.051","article-title":"Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice","volume":"233","author":"Baldo","year":"2012","journal-title":"Behav. Brain Res."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:31:04Z","timestamp":1762421464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050122000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":70,"alternative-id":["S2329050122000572"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2022.04.009","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}